| Literature DB >> 32219846 |
Neelaysh Vukkadala1, Z Jason Qian1, F Christopher Holsinger1, Zara M Patel1, Eben Rosenthal1.
Abstract
The SARS-CoV-2 virus, which causes coronavirus disease 2019 (COVID-19), has rapidly swept across the world since its identification in December 2019. Otolaryngologists are at unique risk due to the close contact with mucus membranes of the upper respiratory tract and have been among the most affected healthcare workers in Wuhan, China. We present information on COVID-19 management relevant to otolaryngologists on the frontlines of this pandemic and provide preliminary guidance based on practices implemented in China and other countries and practical strategies deployed at Stanford University. Laryngoscope, 130:2537-2543, 2020.Entities:
Keywords: COVID-19; SARS-CoV-2; clinical practice guidelines; evidence-based medicine; infectious disease
Mesh:
Year: 2020 PMID: 32219846 DOI: 10.1002/lary.28672
Source DB: PubMed Journal: Laryngoscope ISSN: 0023-852X Impact factor: 3.325